Clinical Trial Update: Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 safety and pharmacokinetic study of LYC-30937 in adults with active ulcerative colitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LYC-30937

Snippet

Sponsor: Lycera Corp. | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED